Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Chart Review Study to Assess the Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program

NCT03768817 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.

NCT NCT03768817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03768817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Chart Review Study to Assess the Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program
Lead sponsor
Ultragenyx Pharmaceutical Inc
Phase
Observational
Overall status
Completed
Start date
January 30, 2019
Completion date
June 8, 2020
Enrollment
20 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

long-chain fatty acid oxidation disorders (lc-faod)